Related Experiment Video
Updated: May 23, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age
Linda L LaGasse1, Chris Derauf, Lynne M Smith
1Brown Center for the Study of Children at Risk, Warren Alpert Medical School at Brown University and Women & Infants Hospital, Providence, RI 02905, USA. linda_lagasse@brown.edu
Insights
Prenatal methamphetamine (MA) exposure is linked to significant behavior problems in children by age 5, including emotional reactivity and attention deficits. This highlights a critical public health issue requiring early intervention strategies.
Area of Science:
- Child Psychology
- Developmental Neuroscience
- Public Health
Background:
- Prenatal exposure to substances like methamphetamine (MA) can impact child development.
- Understanding the long-term behavioral consequences of prenatal MA exposure is crucial for early intervention.
Purpose of the Study:
- To evaluate behavior problems in children with prenatal MA exposure at ages 3 and 5.
- To identify specific behavioral outcomes associated with prenatal MA exposure.
Main Methods:
- Prospective, longitudinal study (Infant Development, Environment, and Lifestyle) with matched exposed and comparison groups.
- Prenatal MA exposure determined by maternal report and/or meconium screening.
- Behavioral assessments using the Child Behavior Checklist at ages 3 and 5, analyzed with general linear mixed models.
Main Results:
- Prenatal MA exposure associated with increased emotional reactivity and anxious/depressed problems at both ages.
- Externalizing and attention-deficit/hyperactivity disorder problems observed by age 5 in exposed children.
- Heavy MA exposure linked to attention problems and withdrawn behavior at both ages.
Conclusions:
- This study is the first to report behavior problems in children as young as 3 years associated with MA exposure.
- Prenatal MA exposure presents a significant public health concern.
- Further follow-up is needed to inform the development of preventive interventions for affected children.
Objective:
We evaluated behavior problems in children who were prenatally exposed to methamphetamine (MA) at ages 3 and 5 years.
Methods:
The Infant Development, Environment, and Lifestyle study, a prospective, longitudinal study of prenatal MA exposure and child outcome, enrolled subjects postpartum in Los Angeles, California; Honolulu, Hawaii; Des Moines, Iowa; and Tulsa, Oklahoma. Prenatal exposure was determined by maternal self-report and/or meconium results. Exposed and comparison groups were matched on race, birth weight, public health insurance, and education. Mothers in the comparison group denied use and had a negative meconium screen for amphetamines. Prenatal exposures to tobacco, alcohol, or marijuana occurred in both groups. At ages 3 and 5 years, 330 children (166 exposed and 164 comparison) were assessed for behavior problems by using the caregiver report on the Child Behavior Checklist. General linear mixed models were used to determine the effects of prenatal MA exposure, including heavy exposure (≥3 days per week), age, and the interaction of exposure and age on behavior problems with adjustment for other drugs of abuse and environmental risk factors.
Results:
MA exposure was associated with increased emotional reactivity and anxious/depressed problems at both ages and externalizing and attention-deficit/hyperactivity disorder problems by age 5 years. Heavy exposure was related to attention problems and withdrawn behavior at both ages. There were no effects of MA on the internalizing or total behavior problems scales.
Conclusions:
This first report of behavior problems in patients as young as 3 years associated with MA exposure identifies an important public health problem. Continued follow-up can inform the development of preventive intervention programs.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Conduct Disorder

